Indivior | L'Utile Operativo



Operating Profit Cambiamento Data
AstraZeneca USD 2.04B 731M 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Glaxosmithkline GBP 702M 513M 2024-12
Halozyme Therapeutics USD 175.5M 12.3M 2024-12
Indivior 4M 136M 2024-09
J&J USD 13.63B 9.74B 2025-03
Kyowa Hakko Kirin JPY 26.93B 2.53B 2024-09
Merck USD 4.3B 369M 2024-12
Novartis USD 3.4B 193M 2024-12
Pfizer USD -409000000 5.57B 2024-12
Sanofi EUR 861M 2.77B 2024-12
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12



Indivior L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.